Loss of protocadherin-17 (PCDH-17) promotes metastasis and invasion through hyperactivation of EGFR/MEK/ERK signaling pathway in hepatocellular carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of protocadherin-17 (PCDH-17) promotes metastasis and invasion through hyperactivation of EGFR/MEK/ERK signaling pathway in hepatocellular carcinoma
Authors
Keywords
Protocadherin-17 (PCDH-17), Hepatocellular carcinoma, Metastasis, ERK, Prognosis
Journal
TUMOR BIOLOGY
Volume 37, Issue 2, Pages 2527-2535
Publisher
Springer Nature
Online
2015-09-19
DOI
10.1007/s13277-015-3970-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reproducibility crisis: Blame it on the antibodies
- (2015) Monya Baker NATURE
- Protocadherins: Not Just Neuron Glue, More Too!
- (2014) Esther T. Stoeckli DEVELOPMENTAL CELL
- Controls for Immunohistochemistry
- (2014) Stephen M. Hewitt et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Protocadherin 17 promoter methylation in tumour tissue from patients with bladder transitional cell carcinoma
- (2014) Xiao-Bo Wang et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Aberrant Methylation of Protocadherin 17 and its Clinical Significance in Patients with Prostate Cancer after Radical Prostatectomy
- (2014) Jian-Guo Ma MEDICAL SCIENCE MONITOR
- Prognostic impact of pERK in advanced hepatocellular carcinoma patients treated with sorafenib
- (2013) D. Chen et al. EJSO
- Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer
- (2013) Zhen-Guo Luo et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Protocadherin-17 function in Zebrafish retinal development
- (2012) Yun Chen et al. Developmental Neurobiology
- DIAPH3 governs the cellular transition to the amoeboid tumour phenotype
- (2012) Martin H. Hager et al. EMBO Molecular Medicine
- Specificity Controls for Immunocytochemistry
- (2012) Silvia Holmseth et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers
- (2012) Xiaotong Hu et al. JOURNAL OF PATHOLOGY
- TCF21andPCDH17methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers
- (2011) Vera L. Costa et al. Epigenetics
- Frequent silencing of protocadherin 17 , a candidate tumour suppressor for esophageal squamous cell carcinoma
- (2010) Shigeo Haruki et al. CARCINOGENESIS
- High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma
- (2010) Maciej Giefing et al. GENES CHROMOSOMES & CANCER
- Cloning and characterization of zebrafish protocadherin–17
- (2009) Sayantanee Biswas et al. DEVELOPMENT GENES AND EVOLUTION
- Expression of protocadherin-9 and protocadherin-17 in the nervous system of the embryonic zebrafish
- (2009) Qin Liu et al. GENE EXPRESSION PATTERNS
- Expression of Cadherin Superfamily Genes in Brain Vascular Development
- (2008) K Krishna et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- A gene signature of nonhealing venous ulcers: Potential diagnostic markers
- (2008) Carlos A. Charles et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started